Perspective.

The ending 2018 was an exceptional year to ND Pharma & Biotech. The company reached and unexpected growth in terms of net sales and revenues. Our products are being distributed all over the world. We are opening several sectors with cutting-edge innovation and developments, so our products and solutions are reaching more and more companies, and therefore more and more people. Our company moved so fast from a biotech start-up to a multinational biopharmaceutical company with lines of development far from imagination and a solid advancing commercial, marketing and sales operative network.

The organization is inspired by a number of mottos, all implied in the structured vision and mission that founders and officials traced from the very beginning. All this is not and never would be possible without the help and dedication of all people around our company, from shareholders that took the risk of financing it, to employees, suppliers, agents, distributors, customers and any other one involved with us, in a loop of friends, as we agree to call to all of them, because we consider to every and one, above any other consideration, a FRIEND.

This friendly environment is the trademark of our company. We want to be loyal to such inspirational value that moves the world alongside other important values to an industry as our. From the universal love, tender, compassion, understanding, care, to the more dedicated people that make such words something more than simple words, transforming each one into something with great significance throughout their acts and behavior, our company is willing to give all those people, enough tools to get some parts of all that done.  This is why we invest some of our efforts to advance some of the most complex issues existing within human health, nutrition, food, animal care and the effort we made to alleviate the burden of all the complications imply from an over-chemical world, and the misuse of such chemical machinery to reach a better society, reducing the exposure to certain chemicals, the intake thru processed foods and aliments, and the problems derived from such practices, most of the time largely ignored by regulators, industry operators and consumers.

Our performance is commencing with the number of achievements our company reached despite the numerous macroeconomic headwinds, including country-specific economic challenges, currency devaluations and higher raw material prices, that are evolving to a high escalade of rising that seems not to be an end.

A few other accomplishments stand out as particularly meaningful to me. First, as is evident from the evolution of our reports even, we are developing ourselves into a brighter and promissory future ahead, reflected in a better and well-optimized business model and product portfolio. The reception and response from our people, employees, customers, suppliers and investors has been quite positive. We are open a world of possibilities thanks to new agreements and project development that led us to open 3 new manufacturing centres under contracting, two of them at two different European member states (Spain and Poland) and the third of them in the United States.

We continue to develop our business network with a strong disembarking in certain countries, mainly in Northern Europe an Russian satellite countries, and expanding in a non-stop growing strategy all across Latin-America, Brazil, Mexico and the U.S, in a world-class level performance with hundreds of targeting companies reaching up our products and improving their own with the help of our company.

As much as we enjoy sharing our success from the ending year, I am also equally enthusiastic about our prospects for the near future. Our divisional societies, our subsidiaries and all the branches of this company group is performing quite well, so this is why we are attracting other companies to act and serve to us as partners in business development and success sharing. We are establishing strong relationships with third parties and companies both within the industrial sector as well as into the great distribution, with some multi-billion dollar companies on our partnership plans, so it´s expected a rush of agreements to launch to the markets, a number of developments that, to be honest, are far from our capacity of market, expressed this in terms of time-planning and marketing organization protocols.

In closing, I want to recognize all the efforts made by our officials and executive management team, supported by our dedicated leaders within the different areas. All of them are serving the company making great contributions. This is why we are expressing publicly here our grateful thanks. 

The last words are for our outstanding employees and executives. We never could be a great company without them and their behavior that is more than a rock-solid foundation. Thanks to the board of directors for their continuing role in guiding and supporting the management of the company. And finally, thanks to our friends, all and one conforming in one way or another, part of this little great family that ND Pharma & Biotech is now.

Our Divisions
A strong constant global expansion
that makes us stronger in certain fields,
countries and territories is the vision behind our aim.
To achieve this objective we do not hesitate in
forming different kinds of association agreements,
joint ventures, partnerships and sometimes entering
in the impulse of certain spin-offs with some of
our existing development ​partners worldwide.